Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

New cancer treatments aim to reduce side effects and improve effectiveness.

Icariside II may help treat gastric cancer by stopping tumor growth.

Pulsed electric field treatment may help the immune system fight liver tumors.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Leydig cell hyperplasia can cause virilization in postmenopausal women and is treatable with surgery.

Short-term side effects of low-dose radioactive iodine therapy are common but temporary.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

PCOS requires personalized treatment to manage symptoms and improve fertility and quality of life.

Most postmenopausal women experience significant skin changes and various skin conditions.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Cancer myths can harm treatment and prevention efforts.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.